PATRICK WHITMAN: Open Payments
NPI 1134764145 · DAMASCUS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 48 payments from 12 companies in 2025. Trend: 2023 $1,412 · 2024 $811 · 2025 $927
Food & beverage: $828Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $202 |
| ABBVIE INC. | 8 | $144 |
| UCB, Inc. | 3 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Organon LLC | 4 | $84 |
| Arcutis Biotherapeutics, Inc. | 3 | $70 |
| E.R. Squibb & Sons, L.L.C. | 4 | $61 |
| Incyte Corporation | 2 | $45 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $32 |
| GENZYME CORPORATION | 1 | $29 |
Products named: TREMFYA, Bimzelx, RINVOQ, COSENTYX, Zoryve, SKYRIZI, DUPIXENT, VTAMA.
Industry payments across MD — which companies pay providers there.
